In the MOD group, intervention with COST and COSM led to a reduction in serum levels of the inflammatory cytokines TNF-α, IL-1β, and IL-6 in the mice, suggesting that both compounds may ameliorate alcoholic hepatitis, albeit with COSM exhibiting slightly superior efficacy compared to COST. The gene discussed is IL6; the disease is alcoholic hepatitis.